
Rainier Acquisition Corp
RNAQURecent IPORainier Acquisition Corp · Nasdaq · Research source · 424B4 · 2026-08-27 · Latest filing · 10-Q · 2026-11-16 SEC ↗
IPO research
The prospectus describes a $75 million SPAC IPO of 7.5 million units at $10.00 per unit, with a 24-month business-combination window and no selected target.
Full source-backed summary
Rainier Acquisition Corp is a newly offered Cayman Islands SPAC seeking $75.0 million before any over-allotment. It has no identified target, and the principal investor considerations are redemption/liquidation uncertainty, sponsor dilution, conflicts of interest and limited operating history.
The prospectus describes a $75 million SPAC IPO of 7.5 million units at $10.00 per unit, with a 24-month business-combination window and no selected target.
- Business and development direction
Rainier Acquisition Corp
Current business Future development
Key risks
Risk 1
Investors do not receive Rule 419 blank-check protections.
Risk 2
Large redemptions may prevent completion of the most desirable business combination or an optimized capital structure.
Risk 3
The sponsor and management may have fiduciary or contractual obligations to other entities and may face conflicts in allocating opportunities.
Sources and calculation notes
Read this report’s SEC filing ↗
| View | Source basis |
|---|---|
| Offering quality | Some sourced inputs are available; a compatible set is needed for this view. Open filing ↗ |
| # | Institution | Underwriting allocation | Ratio · calculated | Units |
|---|---|---|---|---|
| 1 | Chardan Capital Markets LLC | 100.00% | 7,500,000 Units |
Ratio = institution commitment ÷ complete source-table total (7,500,000 Units) × 100.
Underwriting terms
| Measure | Reported value | Unit |
|---|---|---|
| Underwriting discount per unit | $0.35 | $ / security |
| Total underwriting discount | $2,625,000 | $ |
Source and calculation
Prospectus cover; per-unit and total columns as disclosed; no conversion to constituent securities Figures retain their stated source scenario and conditions.
Prospectus cover; per-unit and total columns as disclosed; no conversion to constituent securities
SEC table 2 row 5; source 96696:106439; SHA256 a87567b422c167c748bbf85cbc2f0b0943ceee882a3266830a55ac5cc42755e1 ↗Prospectus cover; per-unit and total columns as disclosed; no conversion to constituent securities Figures retain their stated source scenario and conditions.
Prospectus cover; per-unit and total columns as disclosed; no conversion to constituent securities
SEC table 2 row 5; source 96696:106439; SHA256 a87567b422c167c748bbf85cbc2f0b0943ceee882a3266830a55ac5cc42755e1 ↗IPO CAPITAL QUALITY
Basis and evidence
424B4 · 2026-08-27
The prospectus describes a $75 million SPAC IPO of 7.5 million units at $10.00 per unit, with a 24-month business-combination window and no selected target.
Offering structure
| Measure | Reported value | Unit |
|---|---|---|
| Offering price per unit | $10 | $ / security |
| Gross offering amount | $75,000,000 | $ |
Source and calculation
Prospectus cover; per-unit and total columns as disclosed; no conversion to constituent securities Figures retain their stated source scenario and conditions.
Prospectus cover; per-unit and total columns as disclosed; no conversion to constituent securities
SEC table 2 row 4; source 96696:106439; SHA256 a87567b422c167c748bbf85cbc2f0b0943ceee882a3266830a55ac5cc42755e1 ↗Prospectus cover; per-unit and total columns as disclosed; no conversion to constituent securities Figures retain their stated source scenario and conditions.
Prospectus cover; per-unit and total columns as disclosed; no conversion to constituent securities
SEC table 2 row 4; source 96696:106439; SHA256 a87567b422c167c748bbf85cbc2f0b0943ceee882a3266830a55ac5cc42755e1 ↗Sources and calculation notes
Read this report’s SEC filing ↗
| View | Source basis |
|---|---|
| Use of proceeds | Source-linked structured inputs are not yet available. Open filing ↗ |
Dilution and valuation
Reported figures remain on their stated basis. Exact compatible price and whole-issuer post-offer inputs are required for calculations.
| Calculation | Shares | Value | Reference |
|---|---|---|---|
| Pre-offer shares (as disclosed) | 2,156,250 | — | |
| Pre-offer Units — as disclosed | — | 0 | |
| Post-offer Units — as disclosed | — | 7,694,375 | |
| Pre-offer Ordinary shares — as disclosed | 2,156,250 | — | |
| Post-offer Ordinary shares — as disclosed | 9,569,375 | — | |
| Pre-offer Ordinary shares — as disclosed | 2,156,250 | — | |
| Post-offer warrants — as disclosed | — | 1,923,593 warrants | |
| Offering price per unit | — | $10 | |
| Gross offering amount | — | $75,000,000 |
Basis and evidence ↗
Ordinary shares outstanding before the offering as disclosed; separately stated offering-related forfeiture remains a distinct stage
Figures retain their stated source scenario and conditions.
Prospectus share summary; Number outstanding before this offering; 0; selected security: Units; selected scenario: as disclosed; separately stated forfeiture or conversion is not applied to this printed pre-offer count; no inferred sum, conversion or equity value
Figures retain their stated source scenario and conditions.
Prospectus share summary; Number outstanding after this offering; 7,694,375(1); selected security: Units; selected scenario: as disclosed; no inferred sum, conversion or equity value
Figures retain their stated source scenario and conditions.
Prospectus share summary; Number outstanding before this offering; 2,156,250(2)(3); selected security: Ordinary shares; selected scenario: as disclosed; separately stated forfeiture or conversion is not applied to this printed pre-offer count; no inferred sum, conversion or equity value
Figures retain their stated source scenario and conditions.
Prospectus share summary; Number outstanding after this offering; 9,569,375(1)(2)(4); selected security: Ordinary shares; selected scenario: as disclosed; no inferred sum, conversion or equity value
Figures retain their stated source scenario and conditions.
Prospectus share summary; Ordinary shares outstanding prior to this offering; identical printed pre-offer counts across columns 4,7,10,13,16,19,22,25,28,31; 2,156,250 2,156,250 2,156,250 2,156,250 2,156,250 2,156,250 2,156,250 2,156,250 2,156,250 2,156,250; selected security: Ordinary shares; selected scenario: as disclosed; separately stated forfeiture or conversion is not applied to this printed pre-offer count; no inferred sum, conversion or equity value
Figures retain their stated source scenario and conditions.
Prospectus share summary; Number of warrants to be outstanding after this offering and the sale of private placement warrants; 1,923,593(1); selected security: warrants; selected scenario: as disclosed; no inferred sum, conversion or equity value
Figures retain their stated source scenario and conditions.
Prospectus cover; per-unit and total columns as disclosed; no conversion to constituent securities
Prospectus cover; per-unit and total columns as disclosed; no conversion to constituent securities Figures retain their stated source scenario and conditions.
Exact input · Offering price per unit: $10
Share-count comparison
Compatible whole-issuer pre-offer and post-offer share counts are missing; holder, class-only or offered-share counts cannot substitute for them.
Source ↗IPO valuation scenario simulator
Source inputs required
Compatible source-bound inputs are not available; absence is not a non-disclosure finding.
Source ↗Source and calculation ↗
Source facts remain available under their explicit security, scenario, period and precision; required compatible inputs are incomplete.
Compatible source-bound inputs are not available; absence is not a non-disclosure finding.
Compatible source-bound inputs are not available; absence is not a non-disclosure finding.
Compatible whole-issuer pre-offer and post-offer share counts are missing; holder, class-only or offered-share counts cannot substitute for them.
Source facts remain available under their explicit security, scenario, period and precision; required compatible inputs are incomplete.
Compatible source-bound inputs are not available; absence is not a non-disclosure finding.
The current source URL, accession, hash, proof variants, footnotes, input IDs and executable formulas remain attached. Missing source dates and precision gaps remain explicit.
Sources and calculation notes
Read this report’s SEC filing ↗
| View | Source basis |
|---|---|
| Ownership across stages | Some sourced inputs are available; a compatible set is needed for this view. Open filing ↗ |
- As of
- 2026-08-27
Relationship filters
Select for details · Rainier Acquisition Corp
Holdings and voting rights
Holder groups may overlap; these rows are not an additive ownership partition.
| Holder / measure | Shares | Ownership | Voting rights | Reference |
|---|---|---|---|---|
| our sponsorOwnership as disclosed | — | approximately 20%Beneficial | — | Source statement; approximately ; source predicate: will own; primary source clause; source condition: assuming it does not purchase any units in this offering); source scope: of our issued and outstanding ordinary shares (assuming it does not purchase any units in this offering); not an additive ownership partition |
| Our sponsor, directors and director nomineesOwnership as disclosed | — | 20%Beneficial | — | Source statement; as stated; source predicate: will own; primary source clause; full source conditions retained; source scope: of our outstanding ordinary shares immediately following the completion of this offering; not an additive ownership partition |
| our sponsor, directors and director nomineesOwnership as disclosed | — | 20%Beneficial | — | Source statement; as stated; source predicate: will own; primary source clause; full source conditions retained; source scope: of our issued and outstanding shares after this offering and the expiration of the underwriters’ option to purchase additional units, including 1,875,000 Class B ordinary shares and 194,375 private p; not an additive ownership partition |
| Class A ordinary shares | — | — | 1 votes per shareVotes per share | Literal class voting rights; not a holder voting percentage |
| Class B ordinary shares | — | — | 1 votes per shareVotes per share | Literal class voting rights; not a holder voting percentage |
| Class A ordinary shares | — | — | 1 votes per shareVotes per share | Literal class voting rights; not a holder voting percentage |
| Ravenna 7 LLC (our sponsor)Beneficial shares | 1,944,375 | — | — | Number of; Shares; Beneficially; Owned(2) |
| Gbola Amusa, M.D., CFABeneficial shares | 25,000 | — | — | Number of; Shares; Beneficially; Owned(2) |
| Isaac Manke, Ph.D.Beneficial shares | 25,000 | — | — | Number of; Shares; Beneficially; Owned(2) |
| Jonas GrossmanBeneficial shares | 1,969,375 | — | — | Number of; Shares; Beneficially; Owned(2) |
| Andrew Lam, PharmDBeneficial shares | 25,000 | — | — | Number of; Shares; Beneficially; Owned(2) |
| Chidozie UgwumbaBeneficial shares | 25,000 | — | — | Number of; Shares; Beneficially; Owned(2) |
| All officers, directors and director nominees as a group (6 individuals)Beneficial shares | 2,069,375 | — | — | Number of; Shares; Beneficially; Owned(2) |
| Ravenna 7 LLC (our sponsor)Beneficial ownership | — | 94%Beneficial | — | Approximate Percentage; of Issued and Outstanding; Ordinary Shares; Before; Offering |
| Ravenna 7 LLC (our sponsor)Beneficial ownership | — | 20.3%Beneficial | — | Approximate Percentage; of Issued and Outstanding; Ordinary Shares; After; Offering |
| Gbola Amusa, M.D., CFABeneficial ownership | — | 1.2%Beneficial | — | Approximate Percentage; of Issued and Outstanding; Ordinary Shares; Before; Offering |
| Isaac Manke, Ph.D.Beneficial ownership | — | 1.2%Beneficial | — | Approximate Percentage; of Issued and Outstanding; Ordinary Shares; Before; Offering |
| Jonas GrossmanBeneficial ownership | — | 95.2%Beneficial | — | Approximate Percentage; of Issued and Outstanding; Ordinary Shares; Before; Offering |
| Jonas GrossmanBeneficial ownership | — | 20.6%Beneficial | — | Approximate Percentage; of Issued and Outstanding; Ordinary Shares; After; Offering |
| Andrew Lam, PharmDBeneficial ownership | — | 1.2%Beneficial | — | Approximate Percentage; of Issued and Outstanding; Ordinary Shares; Before; Offering |
| Chidozie UgwumbaBeneficial ownership | — | 1.2%Beneficial | — | Approximate Percentage; of Issued and Outstanding; Ordinary Shares; Before; Offering |
| All officers, directors and director nominees as a group (6 individuals)Beneficial ownership | — | 100%Beneficial | — | Approximate Percentage; of Issued and Outstanding; Ordinary Shares; Before; Offering |
| All officers, directors and director nominees as a group (6 individuals)Beneficial ownership | — | 21.6%Beneficial | — | Approximate Percentage; of Issued and Outstanding; Ordinary Shares; After; Offering |
Source and calculation ↗
Source statement; approximately ; source predicate: will own; primary source clause; source condition: assuming it does not purchase any units in this offering); source scope: of our issued and outstanding ordinary shares (assuming it does not purchase any units in this offering); not an additive ownership partition
Upon closing of this offering, our sponsor will own, on an as-converted basis, approximately 20% of our issued and outstanding ordinary shares (assuming it does not purchase any units in this offering). Accordingly, it may exert a substantial influence on actions requiring a shareholder vote, potentially in a manner that you do not support, including amendments to our amended and restated memorandum and articles of association. If our sponsor purchases any units in this offering or if our sponsor purchases any additional
Source statement; as stated; source predicate: will own; primary source clause; full source conditions retained; source scope: of our outstanding ordinary shares immediately following the completion of this offering; not an additive ownership partition
Our sponsor, directors and director nominees will own, on an as-converted basis, 20% of our outstanding ordinary shares immediately following the completion of this offering. Our sponsor and members of our management team also may from time to time purchase Class A ordinary shares prior to our initial business combination. Our amended and restated memorandum and articles of association will provide that, if we seek shareholder approval, we will complete our initial business combination only if we obtain the approval of an ordinary resolution under Cayman Islands law and our amended and restated memorandum and articles of association. As a result, in addition to our sponsor’s founder shares and private placement shares, we would need 2,715,313, or 28.4% (assuming all issued and outstanding shares are voted and the over-allotment option is not exercised), or no public shareholder votes would be required (assuming only the minimum number of shares representing a quorum are voted and the over-allotment option is not exercised) for an ordinary resolution, or 4,310,209, or 45.0% (assuming all issued and outstanding shares are voted and the over-allotment option is not exercised), and no public shareholder votes would be required (assuming only the minimum number of shares representing a quorum are voted and the over-allotment option is not exercised) for a special resolution, if required, of the 7,500,000 public shares sold in this offering to be voted in favor of an initial business combination in order to have our initial business combination approved. Assuming that only the holders of one-third of our issued and outstanding ordinary shares, representing a quorum under our amended and restated memorandum and articles of association, vote their ordinary shares at a general meeting of the company, we will not need any public shares in addition to our founder shares to be voted in favor of an ordinary resolution approving an initial business combination in order to approve an initial business combination, unless such initial business combination is structured as a statutory merger or consolidation under Cayman Islands law requiring shareholders’ approval by way of a special resolution. Accordingly, if we seek shareholder approval of our initial business combination, the agreement by our sponsor and each member of our management team to vote in favor of our initial business combination will increase the likelihood that we will receive the requisite shareholder approval for such initial business combination.
Source statement; as stated; source predicate: will own; primary source clause; full source conditions retained; source scope: of our issued and outstanding shares after this offering and the expiration of the underwriters’ option to purchase additional units, including 1,875,000 Class B ordinary shares and 194,375 private p; not an additive ownership partition
Prior to the date of this prospectus, there were 2,156,250 Class B ordinary shares issued and outstanding, all of which were held of record by our sponsor, directors and director nominees, including 2,031,250 founder shares held of record by our sponsor and 25,000 founder shares held of record by each of our directors and director nominees, so that, assuming no exercise of the underwriters’ option to purchase additional units (resulting in the forfeiture by our sponsor of 281,250 Class B ordinary shares) and assuming that our sponsor purchases 194,375 private placement units concurrently with the completion of this offering, our sponsor, directors and director nominees will own an aggregate of 20% of our issued and outstanding shares after this offering and the expiration of the underwriters’ option to purchase additional units, including 1,875,000 Class B ordinary shares and 194,375 private placement shares. Upon the closing of this offering, 9,569,375 of our ordinary shares will be outstanding (assuming no exercise of the underwriters’ over-allotment option) including:
Literal class voting rights; not a holder voting percentage
The Company is authorized to issue 100,000,000 Class A ordinary shares with a par value of $0.0001 per share. Holders of the Company’s Class A ordinary shares are entitled to one vote for each share. As of December 31, 2025 and December 31, 2024, there were no shares issued or outstanding.
Literal class voting rights; not a holder voting percentage
The Company is authorized to issue 10,000,000 Class B ordinary shares with a par value of $0.0001 per share. Holders of the Company’s Class B ordinary shares are entitled to one vote for each share.
Literal class voting rights; not a holder voting percentage
The Company is authorized to issue 100,000,000 Class A ordinary shares with a par value of $0.0001 per share. Holders of the Company’s Class A ordinary shares are entitled to one vote for each share. As of June 30, 2026 and December 31, 2025 there were no shares issued or outstanding.
Exact source ownership column: Number of; Shares; Beneficially; Owned(2); holders may overlap; not an additive partition
Raw source column: Number of; Shares; Beneficially; Owned(2); source holder: Ravenna 7 LLC (our sponsor)
Exact source ownership column: Number of; Shares; Beneficially; Owned(2); holders may overlap; not an additive partition
Raw source column: Number of; Shares; Beneficially; Owned(2); source holder: Gbola Amusa, M.D., CFA
Exact source ownership column: Number of; Shares; Beneficially; Owned(2); holders may overlap; not an additive partition
Raw source column: Number of; Shares; Beneficially; Owned(2); source holder: Isaac Manke, Ph.D.
Exact source ownership column: Number of; Shares; Beneficially; Owned(2); holders may overlap; not an additive partition
Raw source column: Number of; Shares; Beneficially; Owned(2); source holder: Jonas Grossman
Exact source ownership column: Number of; Shares; Beneficially; Owned(2); holders may overlap; not an additive partition
Raw source column: Number of; Shares; Beneficially; Owned(2); source holder: Andrew Lam, PharmD
Exact source ownership column: Number of; Shares; Beneficially; Owned(2); holders may overlap; not an additive partition
Raw source column: Number of; Shares; Beneficially; Owned(2); source holder: Chidozie Ugwumba
Exact source ownership column: Number of; Shares; Beneficially; Owned(2); holders may overlap; not an additive partition
Raw source column: Number of; Shares; Beneficially; Owned(2); source holder: All officers, directors and director nominees as a group (6 individuals)
Exact source ownership column: Approximate Percentage; of Issued and Outstanding; Ordinary Shares; Before; Offering; holders may overlap; not an additive partition
Raw source column: Approximate Percentage; of Issued and Outstanding; Ordinary Shares; Before; Offering; source holder: Ravenna 7 LLC (our sponsor)
Exact source ownership column: Approximate Percentage; of Issued and Outstanding; Ordinary Shares; After; Offering; holders may overlap; not an additive partition
Raw source column: Approximate Percentage; of Issued and Outstanding; Ordinary Shares; After; Offering; source holder: Ravenna 7 LLC (our sponsor)
Exact source ownership column: Approximate Percentage; of Issued and Outstanding; Ordinary Shares; Before; Offering; holders may overlap; not an additive partition
Raw source column: Approximate Percentage; of Issued and Outstanding; Ordinary Shares; Before; Offering; source holder: Gbola Amusa, M.D., CFA
Exact source ownership column: Approximate Percentage; of Issued and Outstanding; Ordinary Shares; Before; Offering; holders may overlap; not an additive partition
Raw source column: Approximate Percentage; of Issued and Outstanding; Ordinary Shares; Before; Offering; source holder: Isaac Manke, Ph.D.
Exact source ownership column: Approximate Percentage; of Issued and Outstanding; Ordinary Shares; Before; Offering; holders may overlap; not an additive partition
Raw source column: Approximate Percentage; of Issued and Outstanding; Ordinary Shares; Before; Offering; source holder: Jonas Grossman
Exact source ownership column: Approximate Percentage; of Issued and Outstanding; Ordinary Shares; After; Offering; holders may overlap; not an additive partition
Raw source column: Approximate Percentage; of Issued and Outstanding; Ordinary Shares; After; Offering; source holder: Jonas Grossman
Exact source ownership column: Approximate Percentage; of Issued and Outstanding; Ordinary Shares; Before; Offering; holders may overlap; not an additive partition
Raw source column: Approximate Percentage; of Issued and Outstanding; Ordinary Shares; Before; Offering; source holder: Andrew Lam, PharmD
Exact source ownership column: Approximate Percentage; of Issued and Outstanding; Ordinary Shares; Before; Offering; holders may overlap; not an additive partition
Raw source column: Approximate Percentage; of Issued and Outstanding; Ordinary Shares; Before; Offering; source holder: Chidozie Ugwumba
Exact source ownership column: Approximate Percentage; of Issued and Outstanding; Ordinary Shares; Before; Offering; holders may overlap; not an additive partition
Raw source column: Approximate Percentage; of Issued and Outstanding; Ordinary Shares; Before; Offering; source holder: All officers, directors and director nominees as a group (6 individuals)
Exact source ownership column: Approximate Percentage; of Issued and Outstanding; Ordinary Shares; After; Offering; holders may overlap; not an additive partition
Raw source column: Approximate Percentage; of Issued and Outstanding; Ordinary Shares; After; Offering; source holder: All officers, directors and director nominees as a group (6 individuals)
Economic ownership
A chart needs complete, non-overlapping economic interests on one date and share basis. The disclosed holder figures remain in the table.
Share supply
Source lock-up conditions
| Measure | Reported value |
|---|---|
| We, our sponsor and our officers and directorsAfter date of this prospectus · Source conditions apply | 180 days |
| the private placement warrantsAfter completion of our initial business combination · Source conditions apply | 30 days |
| The private placement unitsAfter completion of our initial business combination · Source conditions apply | 30 days |
| private placement warrantsAfter completion of our initial business combination · Source conditions apply | 30 days |
| private placement unitsAfter completion of our initial business combination · Source conditions apply | 30 days |
| the private placement unitsAfter date of commencement of sales of the offering · Source conditions apply | 180 days |
| The private placement unitsAfter completion of our initial business combination · Source conditions apply | 30 days |
| the founder sharesAfter date of this prospectus · Source conditions apply | 180 days |
| the private placement unitsAfter completion of our initial business combination · Source conditions apply | 30 days |
| the private placement warrantsAfter completion of our initial business combination · Source conditions apply | 30 days |
| the private placement warrantsAfter completion of our initial business combination · Source conditions apply | 30 days |
Source and calculation
We, our sponsor and our officers and directors have agreed that, for a period of 180 days from the date of this prospectus, we and they will not, without the prior written consent of Chardan, offer, sell, contract to sell, pledge, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend or otherwise transfer or dispose of, directly or indirectly, any units, warrants, ordinary shares or any other securities convertible into, or exercisable or exchangeable for, units, warrants or ordinary shares; provided, however, that we may (1) issue and sell the private placement units, (2) issue and sell the additional units to cover our underwriters’ over-allotment option (if any), (3) register with the SEC pursuant to an, agreement to be
SEC lock-up paragraph; source 2073798:2074738; SHA256 def348ff7ba403343fafc5cde38397a99df9788b9584d4f829f43e8bbff7afd5 ↗The private placement units (including the Class A ordinary shares issuable upon exercise of the private placement warrants) will not be transferable, assignable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders, except as described herein under “Principal Shareholders—Transfers of Founder Shares and Private Placement Units.” For more information on the 180 day-transfer restrictions applicable to the securities deemed underwriters’ compensation pursuant to FINRA rules, please see below under “Underwriting (Conflicts of Interest)—Conflicts of Interest, QIU Fees, and Purchase of Private Placement Units and Founder Shares.”
SEC lock-up paragraph; source 348451:349367; SHA256 05e6986e15e9020e2428e8c7e397f110e4f9a70fac12c8763896af857b5c6b80 ↗The founder shares, private placement units and any Class A ordinary shares issued upon conversion or exercise thereof are each subject to transfer restrictions pursuant to lock-up provisions in the agreement entered into by our sponsor and management team. Our sponsor and each member of our management team have agreed not to transfer, assign or sell founder shares until the earlier of (i) the six month anniversary of the completion of our initial business combination and (ii) the date on which the closing price of our Class A ordinary shares exceeds $12.50 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period following our initial business combination; provided that the restriction shall immediately terminate upon the date following the completion of our initial business combination in which we complete a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the public shareholders having the right to exchange their ordinary shares for cash, securities or other property. The private placement units (other than those issued upon conversion of working capital loans) and the respective Class A ordinary shares underlying such units are not transferable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders. The foregoing restrictions are not applicable to transfers (a) to our officers or directors, any affiliates or family members of any of our officers or directors, any members or partners of our sponsor or their affiliates, any affiliates of our sponsor, or any employees of such affiliates; (b) in the case of an individual, by gift to a member of one of the individual’s immediate family or to a trust, the beneficiary of which is a member of the individual’s immediate family, an affiliate of such person or to a charitable organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of the individual; (d) in the case of an individual, pursuant to a qualified domestic relations order; (e) by private sales or transfers made in connection with any forward purchase agreement or similar arrangement or in connection with the consummation of a business combination at prices no greater than the price at which the founder shares, private placement units or Class A ordinary shares, as applicable, were originally purchased; (f) by virtue of our sponsor’s organizational documents upon liquidation or dissolution of our sponsor; (g) to the Company for no value for cancellation in connection with the consummation of our initial business combination; (h) in the event of our liquidation prior to the completion of our initial business combination; or (i) in the event of our completion of a liquidation, merger, share exchange or other similar transaction which results in all of our public shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property subsequent to our completion of our initial business combination; provided, however, that in the case of clauses (a) through (f) these permitted transferees must enter into a written agreement agreeing to be bound by these transfer restrictions and the other restrictions contained in the letter agreement. For more information on the 180 day-transfer restrictions applicable to the securities deemed underwriters’ compensation pursuant to FINRA rules, please see below under “Underwriting (Conflicts of Interest)—Conflicts of Interest, QIU Fees, and Purchase of Private Placement Units and Founder Shares.”
SEC lock-up paragraph; source 1740744:1744693; SHA256 b0f4e19c455a7f168ae582a6009de94ce6586713fd0320f577fd85f6240fc92e ↗Our sponsor has committed, pursuant to a written agreement, to purchase an aggregate of 194,375 private placement units (or 200,000 private placement units if the over-allotment option is exercised in full) for a purchase price of $10.00 per unit in a private placement that will occur simultaneously with the closing of this offering. As such, our sponsor’s interest in this transaction is valued at between $7.60 and $9.70, depending on the number of private placement units purchased. Each private placement unit includes one private placement share and one-quarter of one warrant, each warrant to purchase one Class A ordinary share at $11.50 per share, subject to adjustment. The private placement units (including the Class A ordinary shares and private placement warrants contained therein) may not, subject to certain limited exceptions, be transferred, assigned or sold by the holder until 30 days after the completion of our initial business combination, unless approved by our public shareholders.
SEC lock-up paragraph; source 1747744:1748876; SHA256 07b6cbca35d3008d8e555878bf5042bceb4bf7c8ca9cd904fc329c131f956cf4 ↗The private placement units are identical to the public units issued in this offering, except that the private warrants contained in the private placement units will be non-redeemable and may be exercised on a cashless basis, but in each case only if they are held by the sponsor, subject to certain limited exceptions. The private placement units, other than private placement units issued upon conversion of working capital loans, and the respective Class A ordinary shares underlying such units are not transferable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders.
SEC lock-up paragraph; source 1787924:1788687; SHA256 b4ba097cdd8e6e37fcb19ecf2340d0be4a468fe9e7983dbd306d0da995ebfe4d ↗Except as described below, the private placement warrants have terms and provisions that are identical to those of the warrants being sold as part of the units in this offering; provided, however, that the private placement warrants included in the private placement units that are deemed underwriters’ compensation pursuant to FINRA rules will not be exercisable more than five years from the commencement of sales in this offering in accordance with FINRA Rule 5110(g)(8). Further, the private placement warrants included in the private placement units that are deemed underwriters’ compensation pursuant to FINRA rules will be subject to a lock-up restriction, as required by FINRA Rule 5110(e)(1), and may not be sold during the offering, or sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of such securities by any person for a period of 180 days immediately following the date of commencement of sales of the offering, except as provided in FINRA Rule 5110(e)(2). The private placement warrants (including the Class A ordinary shares issuable upon exercise of the private placement warrants) will not be transferable, assignable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders (except pursuant to limited exceptions as described under “Principal Shareholders—Transfers of Founder Shares and Private Placement Units”; for more information on the 180 day-transfer restrictions applicable to the securities deemed underwriters’ compensation pursuant to FINRA rules, please see below under “Underwriting (Conflicts of Interest)—Conflicts of Interest, QIU Fees, and Purchase of Private Placement Units and Founder Shares”), and they will not be redeemable by us so long as they are held by our sponsor or its permitted transferees (except as otherwise set forth herein). Our sponsor, or its permitted transferees, has the option to exercise the private placement warrants on a cashless basis.
SEC lock-up paragraph; source 1837667:1840091; SHA256 8acb5d1bedac4dde8dcf37e1ec02d55b32afc26ad19e7510571f6a496161ca25 ↗The founder shares, private placement units and any Class A ordinary shares issued upon conversion or exercise thereof are each subject to transfer restrictions pursuant to lock-up provisions in the agreement entered into by our sponsor and management team. Our sponsor and each member of our management team have agreed not to transfer, assign or sell the founder shares for a period ending on the earlier of (i) the six month anniversary of the completion of our initial business combination and (ii) the date on which the closing price of our Class A ordinary shares exceeds $12.50 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period following our initial business combination. The private placement units (other than those issued upon conversion of working capital loans) and the respective Class A ordinary shares underlying such units are not transferable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders. The foregoing restrictions are not applicable to transfers (a) to our officers or directors, any affiliates or family members of any of our officers or directors, any members or partners of our sponsor or their affiliates, any affiliates of our sponsor, or any employees of such affiliates; (b) in the case of an individual, by gift to a member of one of the individual’s immediate family or to a trust, the beneficiary of which is a member of the individual’s immediate family, an affiliate of such person or to a charitable organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of the individual; (d) in the case of an individual, pursuant to a qualified domestic relations order; (e) by private sales or transfers made in connection with any forward purchase agreement or similar arrangement or in connection with the consummation of a business combination at prices no greater than the price at which the founder shares, private placement units or Class A ordinary shares, as applicable, were originally purchased; (f) by virtue of our sponsor’s organizational documents upon liquidation or dissolution of our sponsor; (g) to the Company for no value for cancellation in connection with the consummation of our initial business combination; (h) in the event of our liquidation prior to the completion of our initial business combination; or (i) in the event of our completion of a liquidation, merger, share exchange or other similar transaction which results in all of our public shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property subsequent to our completion of our initial business combination; provided, however, that in the case of clauses (a) through (f) these permitted transferees must enter into a written agreement agreeing to be bound by these transfer restrictions and the other restrictions contained in the letter agreement. For more information, also see “Principal Shareholders—Transfers of Founder Shares and Private Placement Units.” For more information on the 180 day-transfer restrictions applicable to the securities deemed underwriters’ compensation pursuant to FINRA rules, please see below under “—Conflicts of Interest, QIU Fees, and Purchase of Private Placement Units and Founder Shares.”
SEC lock-up paragraph; source 2076438:2080252; SHA256 87ed8c98f057f0c4487e82a52ee6c5fbeed3bcd5d6ba920ed2cd8c0c350e086b ↗Our letter agreement with our sponsor, officers and directors contain provisions relating to transfer restrictions of our founder shares and private placement warrants, indemnification of the trust account, waiver of redemption rights and participation in liquidating distributions from the trust account. The letter agreement may be amended without shareholder approval (although releasing the parties from the restriction not to transfer the founder shares for 180 days following the date of this prospectus will require the prior written consent of the underwriters). While we do not expect our board to approve any amendment to the letter agreement prior to our initial business combination, it may be possible that our board, in exercising its business judgment and subject to its fiduciary duties, chooses to approve one or more amendments to the letter agreement. Any such amendments to the letter agreement would not require approval from our shareholders and may have an adverse effect on the value of an investment in our securities.
SEC lock-up paragraph; source 806691:807852; SHA256 bba8d10b503d05943cd7b766e3caae779b4ae4186705b6a062cf50bd2df87525 ↗assign or sell any of their founder shares until the earliest of (A) one year after the completion of our initial business combination and (B) subsequent to our initial business combination, (x) if the closing price of our Class A ordinary shares exceeds $12.50 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period following our initial business combination, or (y) the date on which we complete a liquidation, merger, share exchange or other similar transaction that results in all of our public shareholders having the right to exchange their ordinary shares for cash, securities or other property. Except as described herein, the private placement units (other than those issued upon conversion of working capital loans) will not be transferable, assignable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders. Because each of our executive officers and director nominees will own ordinary shares or warrants directly or indirectly, they may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination.
SEC lock-up paragraph; source 1686996:1688453; SHA256 5a573f59fbc57f28b556cbc53aace339190a6b79a195e6b83cf4f7d765c928fa ↗Except as described below, the private placement warrants have terms and provisions that are identical to those of the warrants being sold as part of the units in this offering; provided, however, that the private placement warrants included in the private placement units that are deemed underwriters’ compensation pursuant to FINRA rules will not be exercisable more than five years from the commencement of sales in this offering in accordance with FINRA Rule 5110(g)(8). Further, the private placement warrants included in the private placement units that are deemed underwriters’ compensation pursuant to FINRA rules will be subject to a lock-up restriction, as required by FINRA Rule 5110(e)(1), and may not be sold during the offering, or sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of such securities by any person for a period of 180 days immediately following the date of commencement of sales of the offering, except as provided in FINRA Rule 5110(e)(2). The private placement warrants (including the Class A ordinary shares issuable upon exercise of the private placement warrants) will not be transferable, assignable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders (except pursuant to limited exceptions as described under “Principal Shareholders—Transfers of Founder Shares and Private Placement Units”; for more information on the 180 day-transfer restrictions applicable to the securities deemed underwriters’ compensation pursuant to FINRA rules, please see below under “Underwriting (Conflicts of Interest)—Conflicts of Interest, QIU Fees, and Purchase of Private Placement Units and Founder Shares”), and they will not be redeemable by us so long as they are held by our sponsor or its permitted transferees (except as otherwise set forth herein). Our sponsor, or its permitted transferees, has the option to exercise the private placement warrants on a cashless basis.
SEC lock-up paragraph; source 1837667:1840091; SHA256 8acb5d1bedac4dde8dcf37e1ec02d55b32afc26ad19e7510571f6a496161ca25 ↗Except as described herein, our sponsor, officers and directors have agreed not to transfer, assign or sell their founder shares until the earlier of (i) the six month anniversary of the completion of our initial business combination and (ii) the date on which the closing price of our Class A ordinary shares exceeds $12.50 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period following our initial business combination; provided that the restriction shall immediately terminate upon the date following the completion of our initial business combination in which we complete a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the public shareholders having the right to exchange their ordinary shares for cash, securities or other property. Our sponsor, officers and directors have also agreed not to transfer, assign or sell private placement units (including the Class A ordinary shares issuable upon exercise of the private placement warrants) until 30 days after the completion of our initial business combination, unless approved by our public shareholders. Any permitted transferees will be subject to the same restrictions and other agreements of our sponsor with respect to any founder shares. These transfer restrictions terminate upon the completion of a liquidation, merger, share exchange or other similar transaction that results in all of our public shareholders having the right to exchange their ordinary shares for cash, securities or other property. We refer to such transfer restrictions throughout this prospectus as the lock-up.
SEC lock-up paragraph; source 1941422:1943288; SHA256 b3ca2e7d20557f67f4f638e52368f5b860604f353389115c9c9773e6e24c18ac ↗Source lock-up conditions
Literal day restriction; anchor not separately resolved; full conditions and exceptions remain in the source paragraph
| Measure | Reported value |
|---|---|
| the private placement units | 30 days |
| the private placement units | 30 days |
| the private placement units | 30 days |
| the private placement units | 30 days |
| the private placement units | 30 days |
Source and calculation
Repayment of loans which may be made by our sponsor or an affiliate of our sponsor or certain of our officers and directors to finance transaction costs in connection with an intended initial business combination. Up to $1,500,000 of such loans may be convertible into private placement units at a price of $10.00 per private placement unit at the option of the lender. Such private placement units would be identical to the private placement units sold in connection with this offering but will not be subject to a 30-day transfer restriction following our initial business combination. Except for the foregoing, the terms of such loans, if any, have not been determined and no written agreements exist with respect to such loans. Any such payments will be made either (i) prior to our initial business combination using proceeds of this offering and the sale of the private placement units held outside the trust account or from loans made to us by our sponsor or an affiliate of our sponsor or certain of our officers and directors or (ii) in connection with or after the consummation of our initial business combination.
SEC lock-up paragraph; source 431997:433223; SHA256 f17717e16e180e32adae27d97fba86b88fe77f4649a82eec5122e33ca5bdb12c ↗the formation promissory note and the grid promissory note to be used for, among other things, working capital, transaction expenses and other expenses related to this offering and our operations. To date, we have borrowed $25,000 and $78,898.08 under the formation promissory note and grid promissory note, respectively. For a more complete description of the terms of the promissory notes, see “Certain Relationships and Related Party Transactions.” If we are required to seek additional capital, we would need to borrow funds from our sponsor, its affiliates, members of our management team or other third parties to operate or may be forced to liquidate. Neither our sponsor, members of our management team nor their affiliates is under any obligation to us in such circumstances. Any such advances may be repaid only from funds held outside the trust account or from funds released to us upon the completion of our initial business combination. Up to $1,500,000 of such loans may be convertible into private placement units at a price of $10.00 per private placement unit at the option of the lender. Such private placement units would be identical to the private placement units sold in connection with this offering but will not be subject to a 30-day transfer restriction following our initial business combination. Prior to the completion of our initial business combination, we do not expect to seek loans from parties other than our sponsor, its affiliates or members of our management team as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account. If we have not consummated our initial business combination within the required time period because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the trust account. Consequently, our public shareholders may only receive an estimated $10.00 per public share, or possibly less, on our redemption of our public shares, and our warrants will expire worthless. See “—If third parties bring claims against us, the proceeds held in the trust account could be reduced and the per-share redemption amount received by shareholders may be less than $10.00 per public share” and other risk factors herein.
SEC lock-up paragraph; source 609867:612380; SHA256 a896a7c63249e603a29953ce24fe2b572fbf8879fc109120a42e11cb99e847c4 ↗In addition, in order to finance transaction costs in connection with an intended initial business combination, our sponsor or an affiliate of our sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete our initial business combination, we may repay such loaned amounts out of the proceeds of the trust account released to us. Otherwise, such loans may be repaid only out of funds held outside the trust account. In the event that our initial business combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our trust account would be used to repay such loaned amounts. Up to $1,500,000 of such loans may be convertible into private placement units at a price of $10.00 per private placement unit at the option of the lender. Such private placement units would be identical to the private placement units sold in connection with this offering but will not be subject to a 30-day transfer restriction following our initial business combination. Except as set forth above, the terms of such loans, if any, have not been determined and no written agreements exist with respect to such loans. Prior to the completion of our initial business combination, we do not expect to seek loans from parties other than our sponsor, its affiliates or members of our management team as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account.
SEC lock-up paragraph; source 995771:997489; SHA256 94371c8d080e0dc5b857161d7e414d2343a39552f437aea0000b8536c7fc2987 ↗In addition, in order to finance transaction costs in connection with an intended initial business combination, our sponsor or an affiliate of our sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete an initial business combination, we may repay such loaned amounts out of the proceeds of the trust account released to us. In the event that the initial business combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our trust account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into private placement units at a price of $10.00 per private placement unit at the option of the lender. Such private placement units would be identical to the private placement units sold in connection with this offering but will not be subject to a 30-day transfer restriction following our initial business combination. The terms of such loans by our officers and directors, if any, have not been determined and no written agreements exist with respect to such loans. We do not expect to seek loans from parties other than our sponsor, its affiliates or our management team as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account.
SEC lock-up paragraph; source 1753442:1754994; SHA256 409e936bd12c8e0e816d2c4166684d599725098e81e61c266eb3e84cf23a3091 ↗In order to fund working capital deficiencies or finance transaction costs in connection with an intended initial business combination, our sponsor or an affiliate of our sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. Up to $1,500,000 of such loans may be convertible into private placement units at a price of $10.00 per private placement unit at the option of the lender. Such private placement units would be identical to the private placement units sold in connection with this offering but will not be subject to a 30-day transfer restriction following our initial business combination.
SEC lock-up paragraph; source 1843028:1843804; SHA256 0951346a60d9107e1d62e2bad7bf2ed934cf426ee4a1ebfb083f424613e9ce49 ↗Source lock-up conditions
Literal month restriction; after completion of our initial business combination; full conditions and exceptions remain in the source paragraph
| Measure | Reported value |
|---|---|
| private placement unitsAfter completion of our initial business combination · Source conditions apply | 6 months |
Source and calculation
Our sponsor has committed, pursuant to a written agreement, to purchase an aggregate of 194,375 private placement units (or 200,000 private placement units if the over-allotment option is exercised in full) for a purchase price of $10.00 per unit in a private placement that will occur simultaneously with the closing of this offering. As such, our sponsor’s interest in this transaction is valued at between $7.60 and $9.70, depending on the number of private placement units purchased. Each private placement unit includes one private placement share and one-quarter of one warrant, each warrant to purchase one Class A ordinary share at $11.50 per share, subject to adjustment. The private placement units (including the Class A ordinary shares and private placement warrants contained therein) may not, subject to certain limited exceptions, be transferred, assigned or sold by the holder until (i) with respect to 50% of the private placement units, for a period ending the earlier of (A) six months after the completion of our initial business combination and (B) subsequent to our initial business combination, if the closing price of our Class A ordinary shares equals or exceeds $12.50 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period following our initial business combination and (ii) with respect to the other 50% of private placement units, until six months after the completion of our initial business combination, unless approved by our public shareholders
SEC lock-up paragraph; source 1310765:1312522; SHA256 eb6555437cfd8ff0b9a82dfc54656be526f9cdc296597458d1f38735a1e5464a ↗Conditional lock-up timeline
Conditional lock-up timeline
Eligibility is not a sale. Release conditions, holder groups and exceptions remain separate.
date of this prospectus
- We, our sponsor and our officers and directorsWe, our sponsor and our officers and directors have agreed that, for a period of 180 days from the date of this prospectus, we and they will not, without the prior written consent of Chardan, offer, sell, contract to sell, pledge, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend or otherwise transfer or dispose of, directly or indirectly, any units, warrants, ordinary shares or any other securities convertible into, or exercisable or exchangeable for, units, warrants or ordinary shares; provided, however, that we may (1) issue and sell the private placement units, (2) issue and sell the additional units to cover our underwriters’ over-allotment option (if any), (3) register with the SEC pursuant to an, agreement to be
- the founder sharesOur letter agreement with our sponsor, officers and directors contain provisions relating to transfer restrictions of our founder shares and private placement warrants, indemnification of the trust account, waiver of redemption rights and participation in liquidating distributions from the trust account. The letter agreement may be amended without shareholder approval (although releasing the parties from the restriction not to transfer the founder shares for 180 days following the date of this prospectus will require the prior written consent of the underwriters). While we do not expect our board to approve any amendment to the letter agreement prior to our initial business combination, it may be possible that our board, in exercising its business judgment and subject to its fiduciary duties, chooses to approve one or more amendments to the letter agreement. Any such amendments to the letter agreement would not require approval from our shareholders and may have an adverse effect on the value of an investment in our securities.
| Holder / event | Term / date | Conditions |
|---|---|---|
| We, our sponsor and our officers and directors | 180 days | We, our sponsor and our officers and directors have agreed that, for a period of 180 days from the date of this prospectus, we and they will not, without the prior written consent of Chardan, offer, sell, contract to sell, pledge, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend or otherwise transfer or dispose of, directly or indirectly, any units, warrants, ordinary shares or any other securities convertible into, or exercisable or exchangeable for, units, warrants or ordinary shares; provided, however, that we may (1) issue and sell the private placement units, (2) issue and sell the additional units to cover our underwriters’ over-allotment option (if any), (3) register with the SEC pursuant to an, agreement to be |
| the founder shares | 180 days | Our letter agreement with our sponsor, officers and directors contain provisions relating to transfer restrictions of our founder shares and private placement warrants, indemnification of the trust account, waiver of redemption rights and participation in liquidating distributions from the trust account. The letter agreement may be amended without shareholder approval (although releasing the parties from the restriction not to transfer the founder shares for 180 days following the date of this prospectus will require the prior written consent of the underwriters). While we do not expect our board to approve any amendment to the letter agreement prior to our initial business combination, it may be possible that our board, in exercising its business judgment and subject to its fiduciary duties, chooses to approve one or more amendments to the letter agreement. Any such amendments to the letter agreement would not require approval from our shareholders and may have an adverse effect on the value of an investment in our securities. |
completion of our initial business combination
- the private placement warrantsThe private placement units (including the Class A ordinary shares issuable upon exercise of the private placement warrants) will not be transferable, assignable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders, except as described herein under “Principal Shareholders—Transfers of Founder Shares and Private Placement Units.” For more information on the 180 day-transfer restrictions applicable to the securities deemed underwriters’ compensation pursuant to FINRA rules, please see below under “Underwriting (Conflicts of Interest)—Conflicts of Interest, QIU Fees, and Purchase of Private Placement Units and Founder Shares.”
- The private placement unitsThe founder shares, private placement units and any Class A ordinary shares issued upon conversion or exercise thereof are each subject to transfer restrictions pursuant to lock-up provisions in the agreement entered into by our sponsor and management team. Our sponsor and each member of our management team have agreed not to transfer, assign or sell founder shares until the earlier of (i) the six month anniversary of the completion of our initial business combination and (ii) the date on which the closing price of our Class A ordinary shares exceeds $12.50 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period following our initial business combination; provided that the restriction shall immediately terminate upon the date following the completion of our initial business combination in which we complete a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the public shareholders having the right to exchange their ordinary shares for cash, securities or other property. The private placement units (other than those issued upon conversion of working capital loans) and the respective Class A ordinary shares underlying such units are not transferable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders. The foregoing restrictions are not applicable to transfers (a) to our officers or directors, any affiliates or family members of any of our officers or directors, any members or partners of our sponsor or their affiliates, any affiliates of our sponsor, or any employees of such affiliates; (b) in the case of an individual, by gift to a member of one of the individual’s immediate family or to a trust, the beneficiary of which is a member of the individual’s immediate family, an affiliate of such person or to a charitable organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of the individual; (d) in the case of an individual, pursuant to a qualified domestic relations order; (e) by private sales or transfers made in connection with any forward purchase agreement or similar arrangement or in connection with the consummation of a business combination at prices no greater than the price at which the founder shares, private placement units or Class A ordinary shares, as applicable, were originally purchased; (f) by virtue of our sponsor’s organizational documents upon liquidation or dissolution of our sponsor; (g) to the Company for no value for cancellation in connection with the consummation of our initial business combination; (h) in the event of our liquidation prior to the completion of our initial business combination; or (i) in the event of our completion of a liquidation, merger, share exchange or other similar transaction which results in all of our public shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property subsequent to our completion of our initial business combination; provided, however, that in the case of clauses (a) through (f) these permitted transferees must enter into a written agreement agreeing to be bound by these transfer restrictions and the other restrictions contained in the letter agreement. For more information on the 180 day-transfer restrictions applicable to the securities deemed underwriters’ compensation pursuant to FINRA rules, please see below under “Underwriting (Conflicts of Interest)—Conflicts of Interest, QIU Fees, and Purchase of Private Placement Units and Founder Shares.”
- private placement warrantsOur sponsor has committed, pursuant to a written agreement, to purchase an aggregate of 194,375 private placement units (or 200,000 private placement units if the over-allotment option is exercised in full) for a purchase price of $10.00 per unit in a private placement that will occur simultaneously with the closing of this offering. As such, our sponsor’s interest in this transaction is valued at between $7.60 and $9.70, depending on the number of private placement units purchased. Each private placement unit includes one private placement share and one-quarter of one warrant, each warrant to purchase one Class A ordinary share at $11.50 per share, subject to adjustment. The private placement units (including the Class A ordinary shares and private placement warrants contained therein) may not, subject to certain limited exceptions, be transferred, assigned or sold by the holder until 30 days after the completion of our initial business combination, unless approved by our public shareholders.
- private placement unitsThe private placement units are identical to the public units issued in this offering, except that the private warrants contained in the private placement units will be non-redeemable and may be exercised on a cashless basis, but in each case only if they are held by the sponsor, subject to certain limited exceptions. The private placement units, other than private placement units issued upon conversion of working capital loans, and the respective Class A ordinary shares underlying such units are not transferable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders.
- The private placement unitsThe founder shares, private placement units and any Class A ordinary shares issued upon conversion or exercise thereof are each subject to transfer restrictions pursuant to lock-up provisions in the agreement entered into by our sponsor and management team. Our sponsor and each member of our management team have agreed not to transfer, assign or sell the founder shares for a period ending on the earlier of (i) the six month anniversary of the completion of our initial business combination and (ii) the date on which the closing price of our Class A ordinary shares exceeds $12.50 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period following our initial business combination. The private placement units (other than those issued upon conversion of working capital loans) and the respective Class A ordinary shares underlying such units are not transferable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders. The foregoing restrictions are not applicable to transfers (a) to our officers or directors, any affiliates or family members of any of our officers or directors, any members or partners of our sponsor or their affiliates, any affiliates of our sponsor, or any employees of such affiliates; (b) in the case of an individual, by gift to a member of one of the individual’s immediate family or to a trust, the beneficiary of which is a member of the individual’s immediate family, an affiliate of such person or to a charitable organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of the individual; (d) in the case of an individual, pursuant to a qualified domestic relations order; (e) by private sales or transfers made in connection with any forward purchase agreement or similar arrangement or in connection with the consummation of a business combination at prices no greater than the price at which the founder shares, private placement units or Class A ordinary shares, as applicable, were originally purchased; (f) by virtue of our sponsor’s organizational documents upon liquidation or dissolution of our sponsor; (g) to the Company for no value for cancellation in connection with the consummation of our initial business combination; (h) in the event of our liquidation prior to the completion of our initial business combination; or (i) in the event of our completion of a liquidation, merger, share exchange or other similar transaction which results in all of our public shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property subsequent to our completion of our initial business combination; provided, however, that in the case of clauses (a) through (f) these permitted transferees must enter into a written agreement agreeing to be bound by these transfer restrictions and the other restrictions contained in the letter agreement. For more information, also see “Principal Shareholders—Transfers of Founder Shares and Private Placement Units.” For more information on the 180 day-transfer restrictions applicable to the securities deemed underwriters’ compensation pursuant to FINRA rules, please see below under “—Conflicts of Interest, QIU Fees, and Purchase of Private Placement Units and Founder Shares.”
- the private placement unitsassign or sell any of their founder shares until the earliest of (A) one year after the completion of our initial business combination and (B) subsequent to our initial business combination, (x) if the closing price of our Class A ordinary shares exceeds $12.50 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period following our initial business combination, or (y) the date on which we complete a liquidation, merger, share exchange or other similar transaction that results in all of our public shareholders having the right to exchange their ordinary shares for cash, securities or other property. Except as described herein, the private placement units (other than those issued upon conversion of working capital loans) will not be transferable, assignable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders. Because each of our executive officers and director nominees will own ordinary shares or warrants directly or indirectly, they may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination.
- the private placement warrantsExcept as described below, the private placement warrants have terms and provisions that are identical to those of the warrants being sold as part of the units in this offering; provided, however, that the private placement warrants included in the private placement units that are deemed underwriters’ compensation pursuant to FINRA rules will not be exercisable more than five years from the commencement of sales in this offering in accordance with FINRA Rule 5110(g)(8). Further, the private placement warrants included in the private placement units that are deemed underwriters’ compensation pursuant to FINRA rules will be subject to a lock-up restriction, as required by FINRA Rule 5110(e)(1), and may not be sold during the offering, or sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of such securities by any person for a period of 180 days immediately following the date of commencement of sales of the offering, except as provided in FINRA Rule 5110(e)(2). The private placement warrants (including the Class A ordinary shares issuable upon exercise of the private placement warrants) will not be transferable, assignable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders (except pursuant to limited exceptions as described under “Principal Shareholders—Transfers of Founder Shares and Private Placement Units”; for more information on the 180 day-transfer restrictions applicable to the securities deemed underwriters’ compensation pursuant to FINRA rules, please see below under “Underwriting (Conflicts of Interest)—Conflicts of Interest, QIU Fees, and Purchase of Private Placement Units and Founder Shares”), and they will not be redeemable by us so long as they are held by our sponsor or its permitted transferees (except as otherwise set forth herein). Our sponsor, or its permitted transferees, has the option to exercise the private placement warrants on a cashless basis.
- the private placement warrantsExcept as described herein, our sponsor, officers and directors have agreed not to transfer, assign or sell their founder shares until the earlier of (i) the six month anniversary of the completion of our initial business combination and (ii) the date on which the closing price of our Class A ordinary shares exceeds $12.50 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period following our initial business combination; provided that the restriction shall immediately terminate upon the date following the completion of our initial business combination in which we complete a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the public shareholders having the right to exchange their ordinary shares for cash, securities or other property. Our sponsor, officers and directors have also agreed not to transfer, assign or sell private placement units (including the Class A ordinary shares issuable upon exercise of the private placement warrants) until 30 days after the completion of our initial business combination, unless approved by our public shareholders. Any permitted transferees will be subject to the same restrictions and other agreements of our sponsor with respect to any founder shares. These transfer restrictions terminate upon the completion of a liquidation, merger, share exchange or other similar transaction that results in all of our public shareholders having the right to exchange their ordinary shares for cash, securities or other property. We refer to such transfer restrictions throughout this prospectus as the lock-up.
| Holder / event | Term / date | Conditions |
|---|---|---|
| the private placement warrants | 30 days | The private placement units (including the Class A ordinary shares issuable upon exercise of the private placement warrants) will not be transferable, assignable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders, except as described herein under “Principal Shareholders—Transfers of Founder Shares and Private Placement Units.” For more information on the 180 day-transfer restrictions applicable to the securities deemed underwriters’ compensation pursuant to FINRA rules, please see below under “Underwriting (Conflicts of Interest)—Conflicts of Interest, QIU Fees, and Purchase of Private Placement Units and Founder Shares.” |
| The private placement units | 30 days | The founder shares, private placement units and any Class A ordinary shares issued upon conversion or exercise thereof are each subject to transfer restrictions pursuant to lock-up provisions in the agreement entered into by our sponsor and management team. Our sponsor and each member of our management team have agreed not to transfer, assign or sell founder shares until the earlier of (i) the six month anniversary of the completion of our initial business combination and (ii) the date on which the closing price of our Class A ordinary shares exceeds $12.50 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period following our initial business combination; provided that the restriction shall immediately terminate upon the date following the completion of our initial business combination in which we complete a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the public shareholders having the right to exchange their ordinary shares for cash, securities or other property. The private placement units (other than those issued upon conversion of working capital loans) and the respective Class A ordinary shares underlying such units are not transferable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders. The foregoing restrictions are not applicable to transfers (a) to our officers or directors, any affiliates or family members of any of our officers or directors, any members or partners of our sponsor or their affiliates, any affiliates of our sponsor, or any employees of such affiliates; (b) in the case of an individual, by gift to a member of one of the individual’s immediate family or to a trust, the beneficiary of which is a member of the individual’s immediate family, an affiliate of such person or to a charitable organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of the individual; (d) in the case of an individual, pursuant to a qualified domestic relations order; (e) by private sales or transfers made in connection with any forward purchase agreement or similar arrangement or in connection with the consummation of a business combination at prices no greater than the price at which the founder shares, private placement units or Class A ordinary shares, as applicable, were originally purchased; (f) by virtue of our sponsor’s organizational documents upon liquidation or dissolution of our sponsor; (g) to the Company for no value for cancellation in connection with the consummation of our initial business combination; (h) in the event of our liquidation prior to the completion of our initial business combination; or (i) in the event of our completion of a liquidation, merger, share exchange or other similar transaction which results in all of our public shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property subsequent to our completion of our initial business combination; provided, however, that in the case of clauses (a) through (f) these permitted transferees must enter into a written agreement agreeing to be bound by these transfer restrictions and the other restrictions contained in the letter agreement. For more information on the 180 day-transfer restrictions applicable to the securities deemed underwriters’ compensation pursuant to FINRA rules, please see below under “Underwriting (Conflicts of Interest)—Conflicts of Interest, QIU Fees, and Purchase of Private Placement Units and Founder Shares.” |
| private placement warrants | 30 days | Our sponsor has committed, pursuant to a written agreement, to purchase an aggregate of 194,375 private placement units (or 200,000 private placement units if the over-allotment option is exercised in full) for a purchase price of $10.00 per unit in a private placement that will occur simultaneously with the closing of this offering. As such, our sponsor’s interest in this transaction is valued at between $7.60 and $9.70, depending on the number of private placement units purchased. Each private placement unit includes one private placement share and one-quarter of one warrant, each warrant to purchase one Class A ordinary share at $11.50 per share, subject to adjustment. The private placement units (including the Class A ordinary shares and private placement warrants contained therein) may not, subject to certain limited exceptions, be transferred, assigned or sold by the holder until 30 days after the completion of our initial business combination, unless approved by our public shareholders. |
| private placement units | 30 days | The private placement units are identical to the public units issued in this offering, except that the private warrants contained in the private placement units will be non-redeemable and may be exercised on a cashless basis, but in each case only if they are held by the sponsor, subject to certain limited exceptions. The private placement units, other than private placement units issued upon conversion of working capital loans, and the respective Class A ordinary shares underlying such units are not transferable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders. |
| The private placement units | 30 days | The founder shares, private placement units and any Class A ordinary shares issued upon conversion or exercise thereof are each subject to transfer restrictions pursuant to lock-up provisions in the agreement entered into by our sponsor and management team. Our sponsor and each member of our management team have agreed not to transfer, assign or sell the founder shares for a period ending on the earlier of (i) the six month anniversary of the completion of our initial business combination and (ii) the date on which the closing price of our Class A ordinary shares exceeds $12.50 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period following our initial business combination. The private placement units (other than those issued upon conversion of working capital loans) and the respective Class A ordinary shares underlying such units are not transferable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders. The foregoing restrictions are not applicable to transfers (a) to our officers or directors, any affiliates or family members of any of our officers or directors, any members or partners of our sponsor or their affiliates, any affiliates of our sponsor, or any employees of such affiliates; (b) in the case of an individual, by gift to a member of one of the individual’s immediate family or to a trust, the beneficiary of which is a member of the individual’s immediate family, an affiliate of such person or to a charitable organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of the individual; (d) in the case of an individual, pursuant to a qualified domestic relations order; (e) by private sales or transfers made in connection with any forward purchase agreement or similar arrangement or in connection with the consummation of a business combination at prices no greater than the price at which the founder shares, private placement units or Class A ordinary shares, as applicable, were originally purchased; (f) by virtue of our sponsor’s organizational documents upon liquidation or dissolution of our sponsor; (g) to the Company for no value for cancellation in connection with the consummation of our initial business combination; (h) in the event of our liquidation prior to the completion of our initial business combination; or (i) in the event of our completion of a liquidation, merger, share exchange or other similar transaction which results in all of our public shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property subsequent to our completion of our initial business combination; provided, however, that in the case of clauses (a) through (f) these permitted transferees must enter into a written agreement agreeing to be bound by these transfer restrictions and the other restrictions contained in the letter agreement. For more information, also see “Principal Shareholders—Transfers of Founder Shares and Private Placement Units.” For more information on the 180 day-transfer restrictions applicable to the securities deemed underwriters’ compensation pursuant to FINRA rules, please see below under “—Conflicts of Interest, QIU Fees, and Purchase of Private Placement Units and Founder Shares.” |
| the private placement units | 30 days | assign or sell any of their founder shares until the earliest of (A) one year after the completion of our initial business combination and (B) subsequent to our initial business combination, (x) if the closing price of our Class A ordinary shares exceeds $12.50 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period following our initial business combination, or (y) the date on which we complete a liquidation, merger, share exchange or other similar transaction that results in all of our public shareholders having the right to exchange their ordinary shares for cash, securities or other property. Except as described herein, the private placement units (other than those issued upon conversion of working capital loans) will not be transferable, assignable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders. Because each of our executive officers and director nominees will own ordinary shares or warrants directly or indirectly, they may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination. |
| the private placement warrants | 30 days | Except as described below, the private placement warrants have terms and provisions that are identical to those of the warrants being sold as part of the units in this offering; provided, however, that the private placement warrants included in the private placement units that are deemed underwriters’ compensation pursuant to FINRA rules will not be exercisable more than five years from the commencement of sales in this offering in accordance with FINRA Rule 5110(g)(8). Further, the private placement warrants included in the private placement units that are deemed underwriters’ compensation pursuant to FINRA rules will be subject to a lock-up restriction, as required by FINRA Rule 5110(e)(1), and may not be sold during the offering, or sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of such securities by any person for a period of 180 days immediately following the date of commencement of sales of the offering, except as provided in FINRA Rule 5110(e)(2). The private placement warrants (including the Class A ordinary shares issuable upon exercise of the private placement warrants) will not be transferable, assignable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders (except pursuant to limited exceptions as described under “Principal Shareholders—Transfers of Founder Shares and Private Placement Units”; for more information on the 180 day-transfer restrictions applicable to the securities deemed underwriters’ compensation pursuant to FINRA rules, please see below under “Underwriting (Conflicts of Interest)—Conflicts of Interest, QIU Fees, and Purchase of Private Placement Units and Founder Shares”), and they will not be redeemable by us so long as they are held by our sponsor or its permitted transferees (except as otherwise set forth herein). Our sponsor, or its permitted transferees, has the option to exercise the private placement warrants on a cashless basis. |
| the private placement warrants | 30 days | Except as described herein, our sponsor, officers and directors have agreed not to transfer, assign or sell their founder shares until the earlier of (i) the six month anniversary of the completion of our initial business combination and (ii) the date on which the closing price of our Class A ordinary shares exceeds $12.50 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period following our initial business combination; provided that the restriction shall immediately terminate upon the date following the completion of our initial business combination in which we complete a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the public shareholders having the right to exchange their ordinary shares for cash, securities or other property. Our sponsor, officers and directors have also agreed not to transfer, assign or sell private placement units (including the Class A ordinary shares issuable upon exercise of the private placement warrants) until 30 days after the completion of our initial business combination, unless approved by our public shareholders. Any permitted transferees will be subject to the same restrictions and other agreements of our sponsor with respect to any founder shares. These transfer restrictions terminate upon the completion of a liquidation, merger, share exchange or other similar transaction that results in all of our public shareholders having the right to exchange their ordinary shares for cash, securities or other property. We refer to such transfer restrictions throughout this prospectus as the lock-up. |
date of commencement of sales of the offering
- the private placement unitsExcept as described below, the private placement warrants have terms and provisions that are identical to those of the warrants being sold as part of the units in this offering; provided, however, that the private placement warrants included in the private placement units that are deemed underwriters’ compensation pursuant to FINRA rules will not be exercisable more than five years from the commencement of sales in this offering in accordance with FINRA Rule 5110(g)(8). Further, the private placement warrants included in the private placement units that are deemed underwriters’ compensation pursuant to FINRA rules will be subject to a lock-up restriction, as required by FINRA Rule 5110(e)(1), and may not be sold during the offering, or sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of such securities by any person for a period of 180 days immediately following the date of commencement of sales of the offering, except as provided in FINRA Rule 5110(e)(2). The private placement warrants (including the Class A ordinary shares issuable upon exercise of the private placement warrants) will not be transferable, assignable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders (except pursuant to limited exceptions as described under “Principal Shareholders—Transfers of Founder Shares and Private Placement Units”; for more information on the 180 day-transfer restrictions applicable to the securities deemed underwriters’ compensation pursuant to FINRA rules, please see below under “Underwriting (Conflicts of Interest)—Conflicts of Interest, QIU Fees, and Purchase of Private Placement Units and Founder Shares”), and they will not be redeemable by us so long as they are held by our sponsor or its permitted transferees (except as otherwise set forth herein). Our sponsor, or its permitted transferees, has the option to exercise the private placement warrants on a cashless basis.
| Holder / event | Term / date | Conditions |
|---|---|---|
| the private placement units | 180 days | Except as described below, the private placement warrants have terms and provisions that are identical to those of the warrants being sold as part of the units in this offering; provided, however, that the private placement warrants included in the private placement units that are deemed underwriters’ compensation pursuant to FINRA rules will not be exercisable more than five years from the commencement of sales in this offering in accordance with FINRA Rule 5110(g)(8). Further, the private placement warrants included in the private placement units that are deemed underwriters’ compensation pursuant to FINRA rules will be subject to a lock-up restriction, as required by FINRA Rule 5110(e)(1), and may not be sold during the offering, or sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of such securities by any person for a period of 180 days immediately following the date of commencement of sales of the offering, except as provided in FINRA Rule 5110(e)(2). The private placement warrants (including the Class A ordinary shares issuable upon exercise of the private placement warrants) will not be transferable, assignable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders (except pursuant to limited exceptions as described under “Principal Shareholders—Transfers of Founder Shares and Private Placement Units”; for more information on the 180 day-transfer restrictions applicable to the securities deemed underwriters’ compensation pursuant to FINRA rules, please see below under “Underwriting (Conflicts of Interest)—Conflicts of Interest, QIU Fees, and Purchase of Private Placement Units and Founder Shares”), and they will not be redeemable by us so long as they are held by our sponsor or its permitted transferees (except as otherwise set forth herein). Our sponsor, or its permitted transferees, has the option to exercise the private placement warrants on a cashless basis. |
Milestones and unconfirmed releases
| Holder / event | Term / date | Conditions |
|---|---|---|
| the private placement units | 30 days | Repayment of loans which may be made by our sponsor or an affiliate of our sponsor or certain of our officers and directors to finance transaction costs in connection with an intended initial business combination. Up to $1,500,000 of such loans may be convertible into private placement units at a price of $10.00 per private placement unit at the option of the lender. Such private placement units would be identical to the private placement units sold in connection with this offering but will not be subject to a 30-day transfer restriction following our initial business combination. Except for the foregoing, the terms of such loans, if any, have not been determined and no written agreements exist with respect to such loans. Any such payments will be made either (i) prior to our initial business combination using proceeds of this offering and the sale of the private placement units held outside the trust account or from loans made to us by our sponsor or an affiliate of our sponsor or certain of our officers and directors or (ii) in connection with or after the consummation of our initial business combination. |
| the private placement units | 30 days | the formation promissory note and the grid promissory note to be used for, among other things, working capital, transaction expenses and other expenses related to this offering and our operations. To date, we have borrowed $25,000 and $78,898.08 under the formation promissory note and grid promissory note, respectively. For a more complete description of the terms of the promissory notes, see “Certain Relationships and Related Party Transactions.” If we are required to seek additional capital, we would need to borrow funds from our sponsor, its affiliates, members of our management team or other third parties to operate or may be forced to liquidate. Neither our sponsor, members of our management team nor their affiliates is under any obligation to us in such circumstances. Any such advances may be repaid only from funds held outside the trust account or from funds released to us upon the completion of our initial business combination. Up to $1,500,000 of such loans may be convertible into private placement units at a price of $10.00 per private placement unit at the option of the lender. Such private placement units would be identical to the private placement units sold in connection with this offering but will not be subject to a 30-day transfer restriction following our initial business combination. Prior to the completion of our initial business combination, we do not expect to seek loans from parties other than our sponsor, its affiliates or members of our management team as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account. If we have not consummated our initial business combination within the required time period because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the trust account. Consequently, our public shareholders may only receive an estimated $10.00 per public share, or possibly less, on our redemption of our public shares, and our warrants will expire worthless. See “—If third parties bring claims against us, the proceeds held in the trust account could be reduced and the per-share redemption amount received by shareholders may be less than $10.00 per public share” and other risk factors herein. |
| the private placement units | 30 days | In addition, in order to finance transaction costs in connection with an intended initial business combination, our sponsor or an affiliate of our sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete our initial business combination, we may repay such loaned amounts out of the proceeds of the trust account released to us. Otherwise, such loans may be repaid only out of funds held outside the trust account. In the event that our initial business combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our trust account would be used to repay such loaned amounts. Up to $1,500,000 of such loans may be convertible into private placement units at a price of $10.00 per private placement unit at the option of the lender. Such private placement units would be identical to the private placement units sold in connection with this offering but will not be subject to a 30-day transfer restriction following our initial business combination. Except as set forth above, the terms of such loans, if any, have not been determined and no written agreements exist with respect to such loans. Prior to the completion of our initial business combination, we do not expect to seek loans from parties other than our sponsor, its affiliates or members of our management team as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account. |
| the private placement units | 30 days | In addition, in order to finance transaction costs in connection with an intended initial business combination, our sponsor or an affiliate of our sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete an initial business combination, we may repay such loaned amounts out of the proceeds of the trust account released to us. In the event that the initial business combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our trust account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into private placement units at a price of $10.00 per private placement unit at the option of the lender. Such private placement units would be identical to the private placement units sold in connection with this offering but will not be subject to a 30-day transfer restriction following our initial business combination. The terms of such loans by our officers and directors, if any, have not been determined and no written agreements exist with respect to such loans. We do not expect to seek loans from parties other than our sponsor, its affiliates or our management team as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account. |
| the private placement units | 30 days | In order to fund working capital deficiencies or finance transaction costs in connection with an intended initial business combination, our sponsor or an affiliate of our sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. Up to $1,500,000 of such loans may be convertible into private placement units at a price of $10.00 per private placement unit at the option of the lender. Such private placement units would be identical to the private placement units sold in connection with this offering but will not be subject to a 30-day transfer restriction following our initial business combination. |
completion of our initial business combination
- private placement unitsOur sponsor has committed, pursuant to a written agreement, to purchase an aggregate of 194,375 private placement units (or 200,000 private placement units if the over-allotment option is exercised in full) for a purchase price of $10.00 per unit in a private placement that will occur simultaneously with the closing of this offering. As such, our sponsor’s interest in this transaction is valued at between $7.60 and $9.70, depending on the number of private placement units purchased. Each private placement unit includes one private placement share and one-quarter of one warrant, each warrant to purchase one Class A ordinary share at $11.50 per share, subject to adjustment. The private placement units (including the Class A ordinary shares and private placement warrants contained therein) may not, subject to certain limited exceptions, be transferred, assigned or sold by the holder until (i) with respect to 50% of the private placement units, for a period ending the earlier of (A) six months after the completion of our initial business combination and (B) subsequent to our initial business combination, if the closing price of our Class A ordinary shares equals or exceeds $12.50 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period following our initial business combination and (ii) with respect to the other 50% of private placement units, until six months after the completion of our initial business combination, unless approved by our public shareholders
| Holder / event | Term / date | Conditions |
|---|---|---|
| private placement units | 6 months | Our sponsor has committed, pursuant to a written agreement, to purchase an aggregate of 194,375 private placement units (or 200,000 private placement units if the over-allotment option is exercised in full) for a purchase price of $10.00 per unit in a private placement that will occur simultaneously with the closing of this offering. As such, our sponsor’s interest in this transaction is valued at between $7.60 and $9.70, depending on the number of private placement units purchased. Each private placement unit includes one private placement share and one-quarter of one warrant, each warrant to purchase one Class A ordinary share at $11.50 per share, subject to adjustment. The private placement units (including the Class A ordinary shares and private placement warrants contained therein) may not, subject to certain limited exceptions, be transferred, assigned or sold by the holder until (i) with respect to 50% of the private placement units, for a period ending the earlier of (A) six months after the completion of our initial business combination and (B) subsequent to our initial business combination, if the closing price of our Class A ordinary shares equals or exceeds $12.50 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period following our initial business combination and (ii) with respect to the other 50% of private placement units, until six months after the completion of our initial business combination, unless approved by our public shareholders |
Basis and evidence
We, our sponsor and our officers and directors have agreed that, for a period of 180 days from the date of this prospectus, we and they will not, without the prior written consent of Chardan, offer, sell, contract to sell, pledge, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend or otherwise transfer or dispose of, directly or indirectly, any units, warrants, ordinary shares or any other securities convertible into, or exercisable or exchangeable for, units, warrants or ordinary shares; provided, however, that we may (1) issue and sell the private placement units, (2) issue and sell the additional units to cover our underwriters’ over-allotment option (if any), (3) register with the SEC pursuant to an, agreement to be
SEC lock-up paragraph; source 2073798:2074738; SHA256 def348ff7ba403343fafc5cde38397a99df9788b9584d4f829f43e8bbff7afd5 ↗The private placement units (including the Class A ordinary shares issuable upon exercise of the private placement warrants) will not be transferable, assignable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders, except as described herein under “Principal Shareholders—Transfers of Founder Shares and Private Placement Units.” For more information on the 180 day-transfer restrictions applicable to the securities deemed underwriters’ compensation pursuant to FINRA rules, please see below under “Underwriting (Conflicts of Interest)—Conflicts of Interest, QIU Fees, and Purchase of Private Placement Units and Founder Shares.”
SEC lock-up paragraph; source 348451:349367; SHA256 05e6986e15e9020e2428e8c7e397f110e4f9a70fac12c8763896af857b5c6b80 ↗The founder shares, private placement units and any Class A ordinary shares issued upon conversion or exercise thereof are each subject to transfer restrictions pursuant to lock-up provisions in the agreement entered into by our sponsor and management team. Our sponsor and each member of our management team have agreed not to transfer, assign or sell founder shares until the earlier of (i) the six month anniversary of the completion of our initial business combination and (ii) the date on which the closing price of our Class A ordinary shares exceeds $12.50 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period following our initial business combination; provided that the restriction shall immediately terminate upon the date following the completion of our initial business combination in which we complete a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the public shareholders having the right to exchange their ordinary shares for cash, securities or other property. The private placement units (other than those issued upon conversion of working capital loans) and the respective Class A ordinary shares underlying such units are not transferable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders. The foregoing restrictions are not applicable to transfers (a) to our officers or directors, any affiliates or family members of any of our officers or directors, any members or partners of our sponsor or their affiliates, any affiliates of our sponsor, or any employees of such affiliates; (b) in the case of an individual, by gift to a member of one of the individual’s immediate family or to a trust, the beneficiary of which is a member of the individual’s immediate family, an affiliate of such person or to a charitable organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of the individual; (d) in the case of an individual, pursuant to a qualified domestic relations order; (e) by private sales or transfers made in connection with any forward purchase agreement or similar arrangement or in connection with the consummation of a business combination at prices no greater than the price at which the founder shares, private placement units or Class A ordinary shares, as applicable, were originally purchased; (f) by virtue of our sponsor’s organizational documents upon liquidation or dissolution of our sponsor; (g) to the Company for no value for cancellation in connection with the consummation of our initial business combination; (h) in the event of our liquidation prior to the completion of our initial business combination; or (i) in the event of our completion of a liquidation, merger, share exchange or other similar transaction which results in all of our public shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property subsequent to our completion of our initial business combination; provided, however, that in the case of clauses (a) through (f) these permitted transferees must enter into a written agreement agreeing to be bound by these transfer restrictions and the other restrictions contained in the letter agreement. For more information on the 180 day-transfer restrictions applicable to the securities deemed underwriters’ compensation pursuant to FINRA rules, please see below under “Underwriting (Conflicts of Interest)—Conflicts of Interest, QIU Fees, and Purchase of Private Placement Units and Founder Shares.”
SEC lock-up paragraph; source 1740744:1744693; SHA256 b0f4e19c455a7f168ae582a6009de94ce6586713fd0320f577fd85f6240fc92e ↗Our sponsor has committed, pursuant to a written agreement, to purchase an aggregate of 194,375 private placement units (or 200,000 private placement units if the over-allotment option is exercised in full) for a purchase price of $10.00 per unit in a private placement that will occur simultaneously with the closing of this offering. As such, our sponsor’s interest in this transaction is valued at between $7.60 and $9.70, depending on the number of private placement units purchased. Each private placement unit includes one private placement share and one-quarter of one warrant, each warrant to purchase one Class A ordinary share at $11.50 per share, subject to adjustment. The private placement units (including the Class A ordinary shares and private placement warrants contained therein) may not, subject to certain limited exceptions, be transferred, assigned or sold by the holder until 30 days after the completion of our initial business combination, unless approved by our public shareholders.
SEC lock-up paragraph; source 1747744:1748876; SHA256 07b6cbca35d3008d8e555878bf5042bceb4bf7c8ca9cd904fc329c131f956cf4 ↗The private placement units are identical to the public units issued in this offering, except that the private warrants contained in the private placement units will be non-redeemable and may be exercised on a cashless basis, but in each case only if they are held by the sponsor, subject to certain limited exceptions. The private placement units, other than private placement units issued upon conversion of working capital loans, and the respective Class A ordinary shares underlying such units are not transferable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders.
SEC lock-up paragraph; source 1787924:1788687; SHA256 b4ba097cdd8e6e37fcb19ecf2340d0be4a468fe9e7983dbd306d0da995ebfe4d ↗Except as described below, the private placement warrants have terms and provisions that are identical to those of the warrants being sold as part of the units in this offering; provided, however, that the private placement warrants included in the private placement units that are deemed underwriters’ compensation pursuant to FINRA rules will not be exercisable more than five years from the commencement of sales in this offering in accordance with FINRA Rule 5110(g)(8). Further, the private placement warrants included in the private placement units that are deemed underwriters’ compensation pursuant to FINRA rules will be subject to a lock-up restriction, as required by FINRA Rule 5110(e)(1), and may not be sold during the offering, or sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of such securities by any person for a period of 180 days immediately following the date of commencement of sales of the offering, except as provided in FINRA Rule 5110(e)(2). The private placement warrants (including the Class A ordinary shares issuable upon exercise of the private placement warrants) will not be transferable, assignable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders (except pursuant to limited exceptions as described under “Principal Shareholders—Transfers of Founder Shares and Private Placement Units”; for more information on the 180 day-transfer restrictions applicable to the securities deemed underwriters’ compensation pursuant to FINRA rules, please see below under “Underwriting (Conflicts of Interest)—Conflicts of Interest, QIU Fees, and Purchase of Private Placement Units and Founder Shares”), and they will not be redeemable by us so long as they are held by our sponsor or its permitted transferees (except as otherwise set forth herein). Our sponsor, or its permitted transferees, has the option to exercise the private placement warrants on a cashless basis.
SEC lock-up paragraph; source 1837667:1840091; SHA256 8acb5d1bedac4dde8dcf37e1ec02d55b32afc26ad19e7510571f6a496161ca25 ↗The founder shares, private placement units and any Class A ordinary shares issued upon conversion or exercise thereof are each subject to transfer restrictions pursuant to lock-up provisions in the agreement entered into by our sponsor and management team. Our sponsor and each member of our management team have agreed not to transfer, assign or sell the founder shares for a period ending on the earlier of (i) the six month anniversary of the completion of our initial business combination and (ii) the date on which the closing price of our Class A ordinary shares exceeds $12.50 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period following our initial business combination. The private placement units (other than those issued upon conversion of working capital loans) and the respective Class A ordinary shares underlying such units are not transferable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders. The foregoing restrictions are not applicable to transfers (a) to our officers or directors, any affiliates or family members of any of our officers or directors, any members or partners of our sponsor or their affiliates, any affiliates of our sponsor, or any employees of such affiliates; (b) in the case of an individual, by gift to a member of one of the individual’s immediate family or to a trust, the beneficiary of which is a member of the individual’s immediate family, an affiliate of such person or to a charitable organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of the individual; (d) in the case of an individual, pursuant to a qualified domestic relations order; (e) by private sales or transfers made in connection with any forward purchase agreement or similar arrangement or in connection with the consummation of a business combination at prices no greater than the price at which the founder shares, private placement units or Class A ordinary shares, as applicable, were originally purchased; (f) by virtue of our sponsor’s organizational documents upon liquidation or dissolution of our sponsor; (g) to the Company for no value for cancellation in connection with the consummation of our initial business combination; (h) in the event of our liquidation prior to the completion of our initial business combination; or (i) in the event of our completion of a liquidation, merger, share exchange or other similar transaction which results in all of our public shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property subsequent to our completion of our initial business combination; provided, however, that in the case of clauses (a) through (f) these permitted transferees must enter into a written agreement agreeing to be bound by these transfer restrictions and the other restrictions contained in the letter agreement. For more information, also see “Principal Shareholders—Transfers of Founder Shares and Private Placement Units.” For more information on the 180 day-transfer restrictions applicable to the securities deemed underwriters’ compensation pursuant to FINRA rules, please see below under “—Conflicts of Interest, QIU Fees, and Purchase of Private Placement Units and Founder Shares.”
SEC lock-up paragraph; source 2076438:2080252; SHA256 87ed8c98f057f0c4487e82a52ee6c5fbeed3bcd5d6ba920ed2cd8c0c350e086b ↗Our letter agreement with our sponsor, officers and directors contain provisions relating to transfer restrictions of our founder shares and private placement warrants, indemnification of the trust account, waiver of redemption rights and participation in liquidating distributions from the trust account. The letter agreement may be amended without shareholder approval (although releasing the parties from the restriction not to transfer the founder shares for 180 days following the date of this prospectus will require the prior written consent of the underwriters). While we do not expect our board to approve any amendment to the letter agreement prior to our initial business combination, it may be possible that our board, in exercising its business judgment and subject to its fiduciary duties, chooses to approve one or more amendments to the letter agreement. Any such amendments to the letter agreement would not require approval from our shareholders and may have an adverse effect on the value of an investment in our securities.
SEC lock-up paragraph; source 806691:807852; SHA256 bba8d10b503d05943cd7b766e3caae779b4ae4186705b6a062cf50bd2df87525 ↗assign or sell any of their founder shares until the earliest of (A) one year after the completion of our initial business combination and (B) subsequent to our initial business combination, (x) if the closing price of our Class A ordinary shares exceeds $12.50 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period following our initial business combination, or (y) the date on which we complete a liquidation, merger, share exchange or other similar transaction that results in all of our public shareholders having the right to exchange their ordinary shares for cash, securities or other property. Except as described herein, the private placement units (other than those issued upon conversion of working capital loans) will not be transferable, assignable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders. Because each of our executive officers and director nominees will own ordinary shares or warrants directly or indirectly, they may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination.
SEC lock-up paragraph; source 1686996:1688453; SHA256 5a573f59fbc57f28b556cbc53aace339190a6b79a195e6b83cf4f7d765c928fa ↗Except as described below, the private placement warrants have terms and provisions that are identical to those of the warrants being sold as part of the units in this offering; provided, however, that the private placement warrants included in the private placement units that are deemed underwriters’ compensation pursuant to FINRA rules will not be exercisable more than five years from the commencement of sales in this offering in accordance with FINRA Rule 5110(g)(8). Further, the private placement warrants included in the private placement units that are deemed underwriters’ compensation pursuant to FINRA rules will be subject to a lock-up restriction, as required by FINRA Rule 5110(e)(1), and may not be sold during the offering, or sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of such securities by any person for a period of 180 days immediately following the date of commencement of sales of the offering, except as provided in FINRA Rule 5110(e)(2). The private placement warrants (including the Class A ordinary shares issuable upon exercise of the private placement warrants) will not be transferable, assignable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders (except pursuant to limited exceptions as described under “Principal Shareholders—Transfers of Founder Shares and Private Placement Units”; for more information on the 180 day-transfer restrictions applicable to the securities deemed underwriters’ compensation pursuant to FINRA rules, please see below under “Underwriting (Conflicts of Interest)—Conflicts of Interest, QIU Fees, and Purchase of Private Placement Units and Founder Shares”), and they will not be redeemable by us so long as they are held by our sponsor or its permitted transferees (except as otherwise set forth herein). Our sponsor, or its permitted transferees, has the option to exercise the private placement warrants on a cashless basis.
SEC lock-up paragraph; source 1837667:1840091; SHA256 8acb5d1bedac4dde8dcf37e1ec02d55b32afc26ad19e7510571f6a496161ca25 ↗Except as described herein, our sponsor, officers and directors have agreed not to transfer, assign or sell their founder shares until the earlier of (i) the six month anniversary of the completion of our initial business combination and (ii) the date on which the closing price of our Class A ordinary shares exceeds $12.50 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period following our initial business combination; provided that the restriction shall immediately terminate upon the date following the completion of our initial business combination in which we complete a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the public shareholders having the right to exchange their ordinary shares for cash, securities or other property. Our sponsor, officers and directors have also agreed not to transfer, assign or sell private placement units (including the Class A ordinary shares issuable upon exercise of the private placement warrants) until 30 days after the completion of our initial business combination, unless approved by our public shareholders. Any permitted transferees will be subject to the same restrictions and other agreements of our sponsor with respect to any founder shares. These transfer restrictions terminate upon the completion of a liquidation, merger, share exchange or other similar transaction that results in all of our public shareholders having the right to exchange their ordinary shares for cash, securities or other property. We refer to such transfer restrictions throughout this prospectus as the lock-up.
SEC lock-up paragraph; source 1941422:1943288; SHA256 b3ca2e7d20557f67f4f638e52368f5b860604f353389115c9c9773e6e24c18ac ↗Repayment of loans which may be made by our sponsor or an affiliate of our sponsor or certain of our officers and directors to finance transaction costs in connection with an intended initial business combination. Up to $1,500,000 of such loans may be convertible into private placement units at a price of $10.00 per private placement unit at the option of the lender. Such private placement units would be identical to the private placement units sold in connection with this offering but will not be subject to a 30-day transfer restriction following our initial business combination. Except for the foregoing, the terms of such loans, if any, have not been determined and no written agreements exist with respect to such loans. Any such payments will be made either (i) prior to our initial business combination using proceeds of this offering and the sale of the private placement units held outside the trust account or from loans made to us by our sponsor or an affiliate of our sponsor or certain of our officers and directors or (ii) in connection with or after the consummation of our initial business combination.
SEC lock-up paragraph; source 431997:433223; SHA256 f17717e16e180e32adae27d97fba86b88fe77f4649a82eec5122e33ca5bdb12c ↗the formation promissory note and the grid promissory note to be used for, among other things, working capital, transaction expenses and other expenses related to this offering and our operations. To date, we have borrowed $25,000 and $78,898.08 under the formation promissory note and grid promissory note, respectively. For a more complete description of the terms of the promissory notes, see “Certain Relationships and Related Party Transactions.” If we are required to seek additional capital, we would need to borrow funds from our sponsor, its affiliates, members of our management team or other third parties to operate or may be forced to liquidate. Neither our sponsor, members of our management team nor their affiliates is under any obligation to us in such circumstances. Any such advances may be repaid only from funds held outside the trust account or from funds released to us upon the completion of our initial business combination. Up to $1,500,000 of such loans may be convertible into private placement units at a price of $10.00 per private placement unit at the option of the lender. Such private placement units would be identical to the private placement units sold in connection with this offering but will not be subject to a 30-day transfer restriction following our initial business combination. Prior to the completion of our initial business combination, we do not expect to seek loans from parties other than our sponsor, its affiliates or members of our management team as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account. If we have not consummated our initial business combination within the required time period because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the trust account. Consequently, our public shareholders may only receive an estimated $10.00 per public share, or possibly less, on our redemption of our public shares, and our warrants will expire worthless. See “—If third parties bring claims against us, the proceeds held in the trust account could be reduced and the per-share redemption amount received by shareholders may be less than $10.00 per public share” and other risk factors herein.
SEC lock-up paragraph; source 609867:612380; SHA256 a896a7c63249e603a29953ce24fe2b572fbf8879fc109120a42e11cb99e847c4 ↗In addition, in order to finance transaction costs in connection with an intended initial business combination, our sponsor or an affiliate of our sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete our initial business combination, we may repay such loaned amounts out of the proceeds of the trust account released to us. Otherwise, such loans may be repaid only out of funds held outside the trust account. In the event that our initial business combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our trust account would be used to repay such loaned amounts. Up to $1,500,000 of such loans may be convertible into private placement units at a price of $10.00 per private placement unit at the option of the lender. Such private placement units would be identical to the private placement units sold in connection with this offering but will not be subject to a 30-day transfer restriction following our initial business combination. Except as set forth above, the terms of such loans, if any, have not been determined and no written agreements exist with respect to such loans. Prior to the completion of our initial business combination, we do not expect to seek loans from parties other than our sponsor, its affiliates or members of our management team as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account.
SEC lock-up paragraph; source 995771:997489; SHA256 94371c8d080e0dc5b857161d7e414d2343a39552f437aea0000b8536c7fc2987 ↗In addition, in order to finance transaction costs in connection with an intended initial business combination, our sponsor or an affiliate of our sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete an initial business combination, we may repay such loaned amounts out of the proceeds of the trust account released to us. In the event that the initial business combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our trust account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into private placement units at a price of $10.00 per private placement unit at the option of the lender. Such private placement units would be identical to the private placement units sold in connection with this offering but will not be subject to a 30-day transfer restriction following our initial business combination. The terms of such loans by our officers and directors, if any, have not been determined and no written agreements exist with respect to such loans. We do not expect to seek loans from parties other than our sponsor, its affiliates or our management team as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account.
SEC lock-up paragraph; source 1753442:1754994; SHA256 409e936bd12c8e0e816d2c4166684d599725098e81e61c266eb3e84cf23a3091 ↗In order to fund working capital deficiencies or finance transaction costs in connection with an intended initial business combination, our sponsor or an affiliate of our sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. Up to $1,500,000 of such loans may be convertible into private placement units at a price of $10.00 per private placement unit at the option of the lender. Such private placement units would be identical to the private placement units sold in connection with this offering but will not be subject to a 30-day transfer restriction following our initial business combination.
SEC lock-up paragraph; source 1843028:1843804; SHA256 0951346a60d9107e1d62e2bad7bf2ed934cf426ee4a1ebfb083f424613e9ce49 ↗Our sponsor has committed, pursuant to a written agreement, to purchase an aggregate of 194,375 private placement units (or 200,000 private placement units if the over-allotment option is exercised in full) for a purchase price of $10.00 per unit in a private placement that will occur simultaneously with the closing of this offering. As such, our sponsor’s interest in this transaction is valued at between $7.60 and $9.70, depending on the number of private placement units purchased. Each private placement unit includes one private placement share and one-quarter of one warrant, each warrant to purchase one Class A ordinary share at $11.50 per share, subject to adjustment. The private placement units (including the Class A ordinary shares and private placement warrants contained therein) may not, subject to certain limited exceptions, be transferred, assigned or sold by the holder until (i) with respect to 50% of the private placement units, for a period ending the earlier of (A) six months after the completion of our initial business combination and (B) subsequent to our initial business combination, if the closing price of our Class A ordinary shares equals or exceeds $12.50 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period following our initial business combination and (ii) with respect to the other 50% of private placement units, until six months after the completion of our initial business combination, unless approved by our public shareholders
SEC lock-up paragraph; source 1310765:1312522; SHA256 eb6555437cfd8ff0b9a82dfc54656be526f9cdc296597458d1f38735a1e5464a ↗Financial quality
Bars compare absolute amounts within each measure. Each measure has its own scale.
Net income / (loss)
$ · Annual values as reported| Calculation | Reported value |
|---|---|
| Cash and cash equivalents2025-12-31 | $19,238 |
| Current assets2025-12-31 | $24,982 |
| Current assets2024-12-31 | $6,203 |
| Total assets2025-12-31 | $24,982 |
| Total assets2024-12-31 | $6,203 |
| Current liabilities2025-12-31 | $25,000 |
| Total liabilities2025-12-31 | $25,000 |
| General and administrative expensesFY2025 | $6,221 |
| General and administrative expensesFY2024 | $3,800 |
| Net income / (loss)FY2025 | ($6,221) |
| Net income / (loss)FY2024 | ($3,800) |
| Operating cash flowFY2025 | ($5,762) |
| Cash and cash equivalents2026-06-30 · Unaudited | $11,963 |
| Current assets2026-06-30 · Unaudited | $17,707 |
| Total assets2026-06-30 · Unaudited | $91,260 |
| Current liabilities2026-06-30 · Unaudited | $98,553 |
| Total liabilities2026-06-30 · Unaudited | $98,553 |
| Total equity / (deficit)2026-06-30 · Unaudited | ($7,293) |
| Total equity / (deficit)2025-12-31 | ($18) |
| General and administrative expenses6M ended 2026-06-30 · Unaudited | $7,275 |
| Net income / (loss)6M ended 2026-06-30 · Unaudited | ($7,275) |
| Operating cash flow6M ended 2026-06-30 · Unaudited | ($7,275) |
Basis and evidence
Financial quality and runway
Financial quality and runway
The supplied excerpts identify June 30, 2026 as a financial reference date and disclose unaudited equity information, but do not provide sufficient numerical income, cash-flow, balance-sheet or complete capitalization data.
EvidenceFinancial review 1As of June 30, 2026, the excerpt states no Class A shares were issued or outstanding and 2,156,250 Class B shares were issued and outstanding.
+
As of June 30, 2026, the excerpt states no Class A shares were issued or outstanding and 2,156,250 Class B shares were issued and outstanding.
EvidenceFinancial review 2The sponsor formation note had $25,000 outstanding and the grid note had $78,898.08 outstanding as of the prospectus date.
+
The sponsor formation note had $25,000 outstanding and the grid note had $78,898.08 outstanding as of the prospectus date.
MATERIAL CHANGES
The latest material signals and their investor impact are shown below.
Why it mattersThe current filing is Form 424B4 and states that the units have been approved for Nasdaq listing; the prior excerpt stated an intention to apply.
Evidence · Cover and opening disclosure; Ownership and control — later disclosureWhy it mattersThe current evidence states expected delivery on or about August 28, 2026 and identifies the prospectus date as August 26, 2026; the prior excerpt does not provide this same final timetable.
Evidence · Offering — later disclosure424B40001104659-26-102498 ↗
Loading filing history…
Investors do not receive Rule 419 blank-check protections.
- Evidence
- Cover and opening disclosure ↗
Large redemptions may prevent completion of the most desirable business combination or an optimized capital structure.
- Evidence
- Risk factors ↗
The sponsor and management may have fiduciary or contractual obligations to other entities and may face conflicts in allocating opportunities.
- Evidence
- Our Acquisition Process ↗